Want to join the conversation?
$INTC said that for 2Q16 the company expects revenue to be about $13.5Bil, plus or minus $500MM; Non-GAAP GM percentage to be 61%, plus or minus a couple percentage points; R&D plus MG&A spending to be about $5.1Bil; and depreciation to be about $1.5Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?